-
Recent Posts
Categories
- Anesthesiology
- Avandia
- Biomedical Engineering
- Cardiology
- Clinical Trials
- Clinics
- Consumer Products
- Counterfeit Products
- Critical Care Medicine
- Dentistry
- Dermatology
- Emergency Rooms
- Endocrinology
- Eye Care
- Family Practice
- FDA 2011
- FDA 2012
- FDA 2013
- FDA Label Change
- FDA Notice
- FDA Recall
- FDA Safety Communication
- FDA Warning
- Gastroenterology
- Healthcare Professionals
- Hematology
- Home Care
- Hospitals
- Infectious Disease
- Internal Medicine
- Laboratory
- multiple sclerosis (MS)
- Nephrology
- Neurology
- Nursing
- OBGYN
- Oncology
- Ophthalmology
- Orthopaedic Surgery
- Pain Management
- Patients
- Pediatrics
- Pharmacy
- Physical Medicine
- Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Risk Manager
- Surgery
- Uncategorized
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
Category Archives: Pain Management
Symbios GOPump Elastomeric Infusion PumpKit Class 1 Recall
Symbios GOPump Elastomeric Infusion PumpKit: Class 1 Recall – Flow Restrictor Bead May Become Displaced from its Fitting [Posted 03/18/2013] AUDIENCE: Biomedical Engineering, Pain Management, Risk Managers ISSUE: Symbios Medical Products, LLC sent its customers an “URGENT MEDICAL DEVICE … Continue reading
FDA Statement on Fungal Meningitis Outbreak
Fungal Meningitis Outbreak [UPDATE 11-01-2012] Laboratory results from samples of two additional recalled NECC products – preservative free betamethasone and cardioplegia solution – have tested positive for bacterial contamination. FDA and CDC laboratories have identified bacteria present in three separate … Continue reading
Posted in FDA 2012, FDA Warning, Pain Management, Pharmacy, Risk Manager
Tagged drug risks, FDA Statement, FDA Statement on Fungal Meningitis Outbreak, Fungal Meningitis Outbreak, NECC, New England Compounding Center, Pain Medicine, Pharmacists, Risk Managers, updated
Comments Off
Morphine Sulfate Injection USP Carpuject by Hospira Recall
Morphine Sulfate Injection USP, 4 mg/mL (C-II), 1 mL fill in 2.5 mL Carpuject by Hospira, Inc: Recall – May Contain More Than Intended Fill Volume AUDIENCE: Risk Manager, Pain Management ISSUE: Customer report of two Carpujects syringes containing more … Continue reading